Aemetis (NASDAQ:AMTX) Stock Price Crosses Below 200-Day Moving Average – Here’s Why

Aemetis, Inc. (NASDAQ:AMTXGet Free Report)’s stock price crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $2.75 and traded as low as $1.91. Aemetis shares last traded at $1.91, with a volume of 543,144 shares.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on AMTX shares. HC Wainwright reiterated a “buy” rating and set a $28.00 price target on shares of Aemetis in a report on Monday, December 23rd. StockNews.com upgraded shares of Aemetis to a “sell” rating in a report on Wednesday, February 5th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $14.56.

Read Our Latest Report on Aemetis

Aemetis Price Performance

The firm has a market capitalization of $97.70 million, a price-to-earnings ratio of -0.85 and a beta of 1.44. The stock has a fifty day moving average of $2.42 and a two-hundred day moving average of $2.75.

Institutional Trading of Aemetis

Institutional investors and hedge funds have recently bought and sold shares of the stock. ProShare Advisors LLC acquired a new stake in Aemetis in the fourth quarter valued at $27,000. Tower Research Capital LLC TRC boosted its position in Aemetis by 128.8% during the fourth quarter. Tower Research Capital LLC TRC now owns 10,407 shares of the specialty chemicals company’s stock valued at $28,000 after acquiring an additional 5,859 shares during the last quarter. Voya Investment Management LLC bought a new stake in Aemetis during the fourth quarter valued at $28,000. Clear Harbor Asset Management LLC bought a new stake in Aemetis during the fourth quarter valued at $44,000. Finally, Intech Investment Management LLC bought a new stake in Aemetis during the fourth quarter valued at $46,000. 27.02% of the stock is currently owned by institutional investors and hedge funds.

About Aemetis

(Get Free Report)

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.

Further Reading

Receive News & Ratings for Aemetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis and related companies with MarketBeat.com's FREE daily email newsletter.